Verition Fund Management’s CureVac CVAC Stock Holding History

Verition Fund Management’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,034	Closed	-$223K	–	1979
2021 Q2	$223K	Buy	+3,034	New	+$303K	﹤0.01%	1526

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Verition Fund Management's CVAC Position: Q3 2021 in Review

Verition Fund Management sold out of CureVac (CVAC) in Q3 2021, closing a stake of 3,034 shares — an estimated $223K sold.

Verition Fund Management first reported a position in CVAC in Q2 2021 and held it in 1 quarter. The position peaked at $223K in Q2 2021. 111 funds tracked by Wall St. Rank hold CVAC as of Q3 2021.

Verition Fund Management reported no remaining CureVac position as of Q3 2021 after selling out during the quarter.
Verition Fund Management sold 3,034 CureVac shares in Q3 2021, an estimated $223K.
Verition Fund Management first reported a position in CureVac in Q2 2021 and held it in 1 quarter.
Verition Fund Management's CureVac position peaked at $223K in Q2 2021.
111 funds tracked by Wall St. Rank held CureVac as of Q3 2021.

Based on Verition Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.